{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T18:07:44Z","timestamp":1766167664586,"version":"3.48.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T00:00:00Z","timestamp":1756512000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T00:00:00Z","timestamp":1756512000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Jiangxi Provincial Health Commission general science and technology project","award":["202310647"],"award-info":[{"award-number":["202310647"]}]},{"name":"Jiangxi Provincial Department of Education general project","award":["GJJ2200195"],"award-info":[{"award-number":["GJJ2200195"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-025-03642-y","type":"journal-article","created":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T04:09:49Z","timestamp":1756526989000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pars plana vitrectomy followed by subretinal or intravitreal injection with Conbercept and tissue plasminogen activator for clearance of submacular hemorrhage secondary to idiopathic polypoidal choroidal vasculopathy"],"prefix":"10.1007","volume":"45","author":[{"given":"Fan","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lumei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingyao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenghan","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhipeng","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,30]]},"reference":[{"key":"3642_CR1","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/s0039-6257(97)00089-1","volume":"42","author":"MA Hochman","year":"1997","unstructured":"Hochman MA, Seery CM, Zarbin MA (1997) Pathophysiology and management of subretinal hemorrhage. Surv Ophthalmol 42:195\u2013213. https:\/\/doi.org\/10.1016\/s0039-6257(97)00089-1","journal-title":"Surv Ophthalmol"},{"key":"3642_CR2","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1159\/000223948","volume":"44","author":"M Kamei","year":"2009","unstructured":"Kamei M, Tano Y (2009) Tissue plasminogen activator-assisted vitrectomy: surgical drainage of submacular hemorrhage. Dev Ophthalmol 44:82\u201388. https:\/\/doi.org\/10.1159\/000223948","journal-title":"Dev Ophthalmol"},{"key":"3642_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00417-009-1158-7","volume":"248","author":"J Hillenkamp","year":"2010","unstructured":"Hillenkamp J, Surguch V, Framme C, Gabel VP, Sachs HG (2010) Management of submacular hemorrhage with intravitreal versus subretinal injection of recombinant tissue plasminogen activator. Graefes Arch Clin Exp Ophthalmol 248:5\u201311. https:\/\/doi.org\/10.1007\/s00417-009-1158-7","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3642_CR4","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.ajo.2014.12.020","volume":"159","author":"S Kimura","year":"2015","unstructured":"Kimura S, Morizane Y, Hosokawa M et al (2015) Submacular hemorrhage in polypoidal choroidal vasculopathy treated by vitrectomy and subretinal tissue plasminogen activator. Am J Ophthalmol 159:683\u2013689. https:\/\/doi.org\/10.1016\/j.ajo.2014.12.020","journal-title":"Am J Ophthalmol"},{"key":"3642_CR5","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1159\/000438969","volume":"55","author":"J Shao","year":"2016","unstructured":"Shao J, Choudhary MM, Schachat AP (2016) Neovascular age-related macular degeneration. Dev Ophthalmol 55:125\u2013136. https:\/\/doi.org\/10.1159\/000438969","journal-title":"Dev Ophthalmol"},{"key":"3642_CR6","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1097\/IAE.0b013e31824f91e8","volume":"32","author":"A Koh","year":"2012","unstructured":"Koh A, Lee WK, Chen LJ et al (2012) EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy. Retina 32:1453\u20131464. https:\/\/doi.org\/10.1097\/IAE.0b013e31824f91e8","journal-title":"Retina"},{"key":"3642_CR7","doi-asserted-by":"publisher","first-page":"6501","DOI":"10.1167\/iovs.15-17279","volume":"56","author":"Y Niwa","year":"2015","unstructured":"Niwa Y, Kakinoki M, Sawada T, Wang X, Ohji M (2015) Ranibizumab and aflibercept: intraocular pharmacokinetics and their effects on aqueous VEGF level in vitrectomized and nonvitrectomized macaque eyes. Invest Ophthalmol Vis Sci 56:6501\u20136505. https:\/\/doi.org\/10.1167\/iovs.15-17279","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3642_CR8","doi-asserted-by":"publisher","first-page":"e795","DOI":"10.1111\/aos.14386","volume":"98","author":"TT Yao","year":"2020","unstructured":"Yao TT, Yang Y, Jin XL, Wang YX, Zhou YL, Xu AJ, He FL, Wang ZY (2020) Intraocular pharmacokinetics of anti-vascular endothelial growth factor agents by intraoperative subretinal versus intravitreal injection in silicone oil-filled eyes of proliferative diabetic retinopathy: a randomized controlled pilot study. Acta Ophthalmol 98:e795\u2013e800. https:\/\/doi.org\/10.1111\/aos.14386","journal-title":"Acta Ophthalmol"},{"key":"3642_CR9","doi-asserted-by":"publisher","first-page":"2674780","DOI":"10.1155\/2020\/2674780","volume":"2020","author":"TT Yao","year":"2020","unstructured":"Yao TT, Jin XL, Yang Y, Wang YX, Zhou YL, He FL, Wang ZY (2020) Intraocular pharmacokinetics and safety of subretinal injection compared with intravitreal application of conbercept in vitrectomized rabbit eyes. J Ophthalmol 2020:2674780. https:\/\/doi.org\/10.1155\/2020\/2674780","journal-title":"J Ophthalmol"},{"key":"3642_CR10","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1001\/jamaophthalmol.2018.1804","volume":"136","author":"WK Lee","year":"2018","unstructured":"Lee WK, Iida T, Ogura Y et al (2018) Efficacy and safety of intravitreal aflibercept for polypoidal choroidal vasculopathy in the PLANET study: a randomized clinical trial. JAMA Ophthalmol 136:786\u2013793. https:\/\/doi.org\/10.1001\/jamaophthalmol.2018.1804","journal-title":"JAMA Ophthalmol"},{"key":"3642_CR11","doi-asserted-by":"publisher","unstructured":"Koh AH, Expert PCV Panel, Chen LJ et al (2013). Polypoidal choroidal vasculopathy: evidence-based guidelines for clinical diagnosis and treatment. Retina (Philadelphia, Pa), 33(4): 686\u2013716. https:\/\/doi.org\/10.1097\/IAE.0b013e3182852446","DOI":"10.1097\/IAE.0b013e3182852446"},{"issue":"1","key":"3642_CR12","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1186\/s12886-024-03660-x","volume":"24","author":"Y Ma","year":"2024","unstructured":"Ma Y, Rao S, Tan Y et al (2024) Combined treatment of submacular hemorrhage with low-dose subretinal recombinant tissue plasminogen activator and intravitreal conbercept. BMC Ophthalmol 24(1):395. https:\/\/doi.org\/10.1186\/s12886-024-03660-x","journal-title":"BMC Ophthalmol"},{"key":"3642_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0057642","volume":"8","author":"Z Wu","year":"2013","unstructured":"Wu Z, Zhou P, Li X, Wang H, Luo D, Qiao H, Ke X, Huang J (2013) Structural characterization of a recombinant fusion protein by instrumental analysis and molecular modeling. PLoS ONE 8:e57642. https:\/\/doi.org\/10.1371\/journal.pone.0057642","journal-title":"PLoS ONE"},{"key":"3642_CR14","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.exer.2011.09.002","volume":"97","author":"H Li","year":"2012","unstructured":"Li H, Lei N, Zhang M, Li Y, Xiao H, Hao X (2012) Pharmacokinetics of a long-lasting anti-VEGF fusion protein in rabbit. Exp Eye Res 97:154\u2013159. https:\/\/doi.org\/10.1016\/j.exer.2011.09.002","journal-title":"Exp Eye Res"},{"key":"3642_CR15","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1136\/bjo.2003.032466","volume":"88","author":"M Matsuoka","year":"2004","unstructured":"Matsuoka M, Ogata N, Otsuji T, Nishimura T, Takahashi K, Matsumura M (2004) Expression of pigment epithelium derived factor and vascular endothelial growth factor in choroidal neovascular membranes and polypoidal choroidal vasculopathy. Br J Ophthalmol 88:809\u2013815. https:\/\/doi.org\/10.1136\/bjo.2003.032466","journal-title":"Br J Ophthalmol"},{"key":"3642_CR16","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1038\/eye.2016.65","volume":"30","author":"JJ Gonz\u00e1lez-L\u00f3pez","year":"2016","unstructured":"Gonz\u00e1lez-L\u00f3pez JJ, McGowan G, Chapman E, Yorston D (2016) Vitrectomy with subretinal tissue plasminogen activator and ranibizumab for submacular haemorrhages secondary to age-related macular degeneration: retrospective case series of 45 consecutive cases. Eye (Lond) 30:929\u2013935. https:\/\/doi.org\/10.1038\/eye.2016.65","journal-title":"Eye (Lond)"},{"key":"3642_CR17","doi-asserted-by":"publisher","unstructured":"Iglicki M, Khoury M, Donato L, Quispe DJ, Negri HP, Melamud JI (2024) Comparison of subretinal aflibercept vs ranibizumab vs bevacizumab in the context of PPV, pneumatic displacement with subretinal air and subretinal tPA in na\u00efve submacular haemorrhage secondary to nAMD. \"The Submarine Study\". Eye (Lond) 38:292\u20136. https:\/\/doi.org\/10.1038\/s41433-023-02676-9","DOI":"10.1038\/s41433-023-02676-9"},{"key":"3642_CR18","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1159\/000537953","volume":"247","author":"SKH Szeto","year":"2024","unstructured":"Szeto SKH, Tsang CW, Mohamed S et al (2024) Displacement of submacular hemorrhage using subretinal cocktail injection versus pneumatic displacement: a real-world comparative study. Ophthalmologica 247:118\u2013132. https:\/\/doi.org\/10.1159\/000537953","journal-title":"Ophthalmologica"},{"key":"3642_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.xops.2021.100050","volume":"1","author":"FFL Reichel","year":"2021","unstructured":"Reichel FFL, Wozar F, Seitz I, Ochakovski A, Bartz-Schmidt KU, Peters T, Fischer MD (2021) An optimized treatment protocol for subretinal injections limits intravitreal vector distribution. Ophthalmol Sci 1:100050. https:\/\/doi.org\/10.1016\/j.xops.2021.100050","journal-title":"Ophthalmol Sci"},{"key":"3642_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fddev.2023.1148795","author":"S Koponen","year":"2023","unstructured":"Koponen S, Kokki E, Tamminen T, Yl\u00e4-Herttuala S (2023) AAV2 and AAV9 tropism and transgene expression in the mouse eye and major tissues after intravitreal and subretinal delivery. Front Drug Deliv. https:\/\/doi.org\/10.3389\/fddev.2023.1148795","journal-title":"Front Drug Deliv"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-025-03642-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-025-03642-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-025-03642-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T18:02:54Z","timestamp":1766167374000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-025-03642-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,30]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3642"],"URL":"https:\/\/doi.org\/10.1007\/s10792-025-03642-y","relation":{},"ISSN":["1573-2630"],"issn-type":[{"type":"electronic","value":"1573-2630"}],"subject":[],"published":{"date-parts":[[2025,8,30]]},"assertion":[{"value":"13 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This work has been carried out in accordance with the Declaration of Helsinki (2000) of the World Medical Association. This work was approved by the Ethics Committee of Nanchang University Affiliated Eye Hospital (YLP20221220). Written informed consent was exempted due to the retrospective nature of the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"364"}}